Protective effects of Sapindus saponins in spontaneously hypertensive rats
Back to article page
OriginalPaper|Updated:2021-08-27
|
Protective effects of Sapindus saponins in spontaneously hypertensive rats
Protective effects of Sapindus saponins in spontaneously hypertensive rats
中国结合医学杂志(英文版)2015年21卷第1期 页码:36-42
Affiliations:
1. Department of Pharmacology, Anhui Medical University,Hefei,China
2. Department of Pharmacology, Anhui University of Traditional Chinese Medicine,Hefei,China
3. Anqing Medical and Pharmaceutical College,Anhui Province,Anqing,China
Author bio:
Funds:
Supported by the Foundation for Young Talents in College of Anhui Province under Grant (No. 2009SQRZ114) and Youth Scientific Research Foundation of Anhui University of Traditional Chinese Medicine (No. 2012QN005).
Chen, M., Chen, Zw., Long, Zj. et al. Protective effects of Sapindus saponins in spontaneously hypertensive rats., Chin. J. Integr. Med. 21, 36–42 (2015). https://doi.org/10.1007/s11655-013-1464-0
Ming Chen, Zhi-wu Chen, Zi-jiang Long, et al. Protective effects of Sapindus saponins in spontaneously hypertensive rats[J]. Chinese Journal of Integrative Medicine, 2015,21(1):36-42.
Chen, M., Chen, Zw., Long, Zj. et al. Protective effects of Sapindus saponins in spontaneously hypertensive rats., Chin. J. Integr. Med. 21, 36–42 (2015). https://doi.org/10.1007/s11655-013-1464-0DOI:
Ming Chen, Zhi-wu Chen, Zi-jiang Long, et al. Protective effects of Sapindus saponins in spontaneously hypertensive rats[J]. Chinese Journal of Integrative Medicine, 2015,21(1):36-42. DOI: 10.1007/s11655-013-1464-0.
Protective effects of Sapindus saponins in spontaneously hypertensive rats
摘要
To investigate the protective effects of Sapindus saponins in spontaneously hypertensive rats
and the possible cellular and molecular mechanisms. Thirty-two 16-week-old spontaneously hypertensive rats were randomly divided into four groups (8 in each group): model group (placebo)
positive control group (27 mg/kg of Captopril Tablets)
Sapindus saponins groups (27 mg/kg and 108 mg/kg
respectively). Another 8 healthy Wistar-Kyoto strain (WKY) rats were used as the normal group. The animals were treated for 8 weeks. Blood pressure of rats was determined by non-invasive blood pressure meter (BP-6). Furthermore
the contents of angiotensin II (Ang II) in plasma and myocardial tissue were determined by enzyme-linked immunosorbent assay (ELISA)
the gene expression of receptor angiotensin type 1 (AT1R) in aorta was determined by quantitative realtime polymerase chain reaction (qRT-PCR). The protein expression of transforming growth factor-β1 (TGF-β1) and AT1R in heart was determined by immunohistochemical staining. The protein expression of p-phosphorylation of p38 mitogen-activated protein kinase (p-p38MAPK) was determined by Western blotting. The contents of interleukin (IL)-1
IL-6 and tumor necrosis factor (TNF) in serum were determined by radioimmunoassay. And the histopathological and morphological changes of aorta and heart tissue samples were assessed semi-quantitatively by hematoxylin-eosin (HE) or Masson staining. Thirty minutes after single or continuous treatment
systolic blood pressure (SBP) was reduced significantly in Sapindus saponins groups. And the contents of AngII
IL-1
IL-6 and TNF-α in serum
the expression of AT1R mRNA
p-p38MAPK and TGF-β1 were significantly suppressed dose-dependently (P<0.05 or P<0.01). With the Sapindus saponins treatment
compared with those of the model group
the cardiac and aortic pathological changes were ameliorated significantly. Our findings suggest that Sapindus saponins might have protective effects in spontaneously hypertensive rats
the cellular and molecular mechanisms of which might be relevant to the regulation of inflammatory responses mediated by p-p38MAPK signal pathway based on activated Ang II and AT1R.
Abstract
To investigate the protective effects of Sapindus saponins in spontaneously hypertensive rats
and the possible cellular and molecular mechanisms. Thirty-two 16-week-old spontaneously hypertensive rats were randomly divided into four groups (8 in each group): model group (placebo)
positive control group (27 mg/kg of Captopril Tablets)
Sapindus saponins groups (27 mg/kg and 108 mg/kg
respectively). Another 8 healthy Wistar-Kyoto strain (WKY) rats were used as the normal group. The animals were treated for 8 weeks. Blood pressure of rats was determined by non-invasive blood pressure meter (BP-6). Furthermore
the contents of angiotensin II (Ang II) in plasma and myocardial tissue were determined by enzyme-linked immunosorbent assay (ELISA)
the gene expression of receptor angiotensin type 1 (AT1R) in aorta was determined by quantitative realtime polymerase chain reaction (qRT-PCR). The protein expression of transforming growth factor-β1 (TGF-β1) and AT1R in heart was determined by immunohistochemical staining. The protein expression of p-phosphorylation of p38 mitogen-activated protein kinase (p-p38MAPK) was determined by Western blotting. The contents of interleukin (IL)-1
IL-6 and tumor necrosis factor (TNF) in serum were determined by radioimmunoassay. And the histopathological and morphological changes of aorta and heart tissue samples were assessed semi-quantitatively by hematoxylin-eosin (HE) or Masson staining. Thirty minutes after single or continuous treatment
systolic blood pressure (SBP) was reduced significantly in Sapindus saponins groups. And the contents of AngII
IL-1
IL-6 and TNF-α in serum
the expression of AT1R mRNA
p-p38MAPK and TGF-β1 were significantly suppressed dose-dependently (P<0.05 or P<0.01). With the Sapindus saponins treatment
compared with those of the model group
the cardiac and aortic pathological changes were ameliorated significantly. Our findings suggest that Sapindus saponins might have protective effects in spontaneously hypertensive rats
the cellular and molecular mechanisms of which might be relevant to the regulation of inflammatory responses mediated by p-p38MAPK signal pathway based on activated Ang II and AT1R.
关键词
Sapindus saponinshypertensionrenin-angiotensin-aldosterone systemphosphorylation of p38 mitogen-activated protein kinase pathway (p-p38 MAPK)
Keywords
Sapindus saponinshypertensionrenin-angiotensin-aldosterone systemphosphorylation of p38 mitogen-activated protein kinase pathway (p-p38 MAPK)
references
Pauletto P, Rattazzi M. Inflammation and hypertension: the search for a link. Nephrol Dial Transplant 2006;21:850–853.
Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, Ardouin P, et al. Specific abrogation of transforming growth factor-β signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 2003;102:4052–4058.
Brown R, Thompson HJ, Imran SA, Ur E, Wilkinson M. Traumatic brain injury induces adipokine gene expression in rat brain. Neurosci Lett 2008;432(1):73–78.
Blacher J, Guerin A, Pannier B, Marchais S, Safar M, London G. Impact of aortic stiffness on survival in endstage renal disease. Circulation 1999;99:2434–2439.
Hayaishi-Okano R, Yamasaki Y, Katakami N, Ohtoshi K, Gorogava S, Kuroda A, et al. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 2002;25:1432–1438.
Badr K, Wainwright CL. Inflammation in the cardiovascular system: here, there and everywhere. Curr Opin Pharmacol 2004;4(2):107–109.
Lim W, Ma W, Gee K, Aucoin S, Nandan D, Diaz-Mitoma F, et al. Distinct role of p38 and c-Jun N-Terminal kinases in IL-10-dependent and IL-10-independen regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulate human monocytic cells. J Immunol 2002;168:1759–1769.
Pereda J, Sabater L, Cassinello N, Gomez-Cambronero L, Closa D, Folch-Puy E, et al. Effect of simultaneous inhibition of TNF-α production and xanthine oxidas in experimental acute pancreatitis the role of mitogen activated protein kinase. Ann Surg 2004;240(1):108–116.
Rius C, Abu-Taha M, Hermenegildo C, Piqueras L, Cerda-Nicolas J, Issekutz AC, et al. Trans — but not -resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-B activation and peroxisome proliferator-activated receptor-upregulation. J Immunol 2010;185:3718–3727.
Ojha P, Maikhuri JP, Gupta G. Effect of spermicides on Lactobacillus acidophilus in vitrononoxynol-9 vs. Sapindus saponins. Contraception 2003;68:135–138.
Aruluozhi DK, Veeranjaneyulu A, Bodhankar SL. Arora SK. Pharmacological studies of the aqueous extract of Sapindus trifoliatus on central nervous system: possible antimigraine mechanisms. Ethnopharmacology 2005;97:491–496.
Tousoulis D, Papageorgiou N, Androulakis E, Paroutoglou K, Stefanadis C. Novel therapeutic strategies targeting vascular endothelium in essential hypertension. Expert Opin Invest Drugs 2010;19:1395–1412.
Burckle CA, Danser AHJ, Muller DN, Garrelds IM, Gasc JM, Popova E, et al. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 2006;47:552–556.
Johnson FK, Johnson RA, Peyton KJ, Durante W. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physio 2005;288:1057–1062.
Creemers EE, Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 2011;89(2):265–272.